Filippo Rossi

Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines.

Recycling asymmetric hydrogenation catalysts by their immobilisation onto ion-exchange resins.

Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in beta-amyloid peptide-dependent cell death.

The expression of p75 neurotrophin receptor protects against the neurotoxicity of soluble oligomers of beta-amyloid.

Health-promoting substances and heavy metal content in tomatoes grown with different farming techniques.

Absence of allergic reactions to egg white lysozyme additive in Grana Padano cheese.

Astrocytes regulate the expression of insulin-like growth factor 1 receptor (IGF1-R) in primary cortical neurons during in vitro senescence.

Antisecretory factor as a potential health-promoting molecule in man and animals.

Hydrogel for cell housing in the brain and in the spinal cord.

Characterization and degradation behavior of agar-carbomer based hydrogels for drug delivery applications: solute effect.

Structural characterization of poly-l-lactic acid (P(L)LA) and poly(glycolic acid)(PGA) oligomers.

Plasma ochratoxin A levels, food consumption, and risk biomarkers of a representative sample of men and women from the Molise region in Italy.

Multiple drug delivery hydrogel system for spinal cord injury repair strategies.

Short-term modifications in the distal gut microbiota of weaning mice induced by a high-fat diet.

Bioresorbable polymer coated drug eluting stent: a model study.

Hydrogels in spinal cord injury repair strategies.

Current options for drug delivery to the spinal cord.

Tunable hydrogel-nanoparticles release system for sustained combination therapies in the spinal cord.

The nutrigenomic investigation of C57BL/6N mice fed a short-term high-fat diet highlights early changes in clock genes expression.

Immunological response in egg-sensitive adults challenged with cheese containing or not containing lysozyme.

Selective nanovector mediated treatment of activated proinflammatory microglia/macrophages in spinal cord injury.

Polymer functionalization as a powerful tool to improve scaffold performances.

Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury.

Se-(2-aminoalkyl)selenocysteines as biochemical redox agents. A tool to contrast cell injury induced by aflatoxin B1 in HepG2 cells.

Pasta supplemented with isolated lupin protein fractions reduces body weight gain and food intake of rats and decreases plasma glucose concentration upon glucose overload trial.

Polymeric scaffolds as stem cell carriers in bone repair.

Nanovector-mediated drug delivery for spinal cord injury treatment.

Sustained Delivery of Chondroitinase ABC from Hydrogel System.

Gut response induced by weaning in piglet features marked changes in immune and inflammatory response.

Mathematical modeling of PLGA microparticles: from polymer degradation to drug release.

Polymer hydrogel functionalized with biodegradable nanoparticles as composite system for controlled drug delivery.

Drug-Polymer Interactions in Hydrogel-based Drug-Delivery Systems: An Experimental and Theoretical Study.

Early modulation of pro-inflammatory microglia by minocycline loaded nanoparticles confers long lasting protection after spinal cord injury.

A new three dimensional biomimetic hydrogel to deliver factors secreted by human mesenchymal stem cells in spinal cord injury.

Non-invasive in vitro and in vivo monitoring of degradation of fluorescently labeled hyaluronan hydrogels for tissue engineering applications.

Food for Healthy Living and Active Ageing.

Modulators of microglia: a patent review.

Tunable drug delivery using chemoselective functionalization of hydrogels.

The Role of Drug-Drug Interactions in Hydrogel Delivery Systems: Experimental and Model Study.

OS 04-04 ANTIHYPERTENSIVE EFFECT OF MILK-DERIVATIVE TRIPEPTIDES. RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ON THE EFFECTS OF GRANA PADANO CHEESE DOP IN HYPERTENSIVE PATIENTS.